AUG 15, 2022 6:30 AM PDT

New Drug Candidate Treats Over 300 Drug Resistant Bacteria

WRITTEN BY: Annie Lennon

Researchers have developed a new drug candidate that shows promise in inhibiting over 300 drug-resistant bacteria, including those that cause pneumonia and urinary tract infections. The corresponding study was published in ACS Publications

Gram-negative bacteria are a class of microbes that affect millions of people worldwide. They are characterized by strong cell walls that make them increasingly resistant to available antibiotics, and thus notoriously difficult to treat. Effective treatment options often have negative side effects on other forms of bacteria- including those that are so-called 'healthy'. This in mind, scientists are keen to design drugs that infiltrate the defenses of gram-negative bacteria while leaving other microbes intact. 

For the present study, researchers noted that a promising target for gram-negative bacterial defenses is the enzyme FabI, which is known to catalyze bacterial fatty acid biosynthesis. Currently, FAb1 inhibitors are in clinical trials for treating infections involving Staphylococcus aureus- a gram-positive bacteria. The researchers thus decided to investigate whether drugs targeting FabI could also be effective for gram-negative bacteria.

To do so, they synthesized a suite of Fab1 inhibitors and tested them against various gram-negative bacteria. They found that one such inhibitor, called fabimycin, was effective against over 300 drug-resistant clinical isolates. The same drug remained harmless against certain gram-positive pathogens and ‘healthy’ bacteria common in the body. 

They also found that fabimycin reduced amounts of drug-resistant bacteria in mice with pneumonia and urinary tract infections to pre-infection levels or lower. The experimental drug, they noted, performed similarly, if not better, than existing antibiotics at similar doses. 

“Fabimycin has translational promise, and its discovery provides additional evidence that antibiotics can be systematically modified to accumulate in Gram-negative bacteria and kill these problematic pathogens,” wrote the researchers in their paper. 


Sources: Science Daily, ACS Publications

About the Author
University College London
Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
AUG 02, 2022
Neuroscience
Brain Derived Exosomes; a non-invasive look inside the brain
AUG 02, 2022
Brain Derived Exosomes; a non-invasive look inside the brain
Exosomes are small extracellular vesicles about the size of influenza and corona viruses and have been making news for s ...
JUL 16, 2022
Drug Discovery & Development
Whole Blood Exchange May Reduce Amyloid Plaques in Alzheimer's
JUL 16, 2022
Whole Blood Exchange May Reduce Amyloid Plaques in Alzheimer's
Whole blood exchange reduces the formation of amyloid beta plaques in mouse models of Alzheimer's disease. The corre ...
AUG 11, 2022
Cannabis Sciences
High Doses of CBD Safe for Driving
AUG 11, 2022
High Doses of CBD Safe for Driving
The University of Sydney research team studied the effects of cannabidiol (CBD) on driving, and they found that the high ...
AUG 07, 2022
Drug Discovery & Development
Monoclonal Antibody Treatment Shows Promise in Preventing Malaria
AUG 07, 2022
Monoclonal Antibody Treatment Shows Promise in Preventing Malaria
A singular injection of a monoclonal antibody treatment candidate has been shown as safe and highly protective in US adu ...
AUG 09, 2022
Microbiology
An Inhaled COVID-19 Treatment Halts Viral Replication
AUG 09, 2022
An Inhaled COVID-19 Treatment Halts Viral Replication
This new approach could also be effective against many different types of RNA viruses.
SEP 11, 2022
Cannabis Sciences
Smashing Stereotypes of Cannabis Users
SEP 11, 2022
Smashing Stereotypes of Cannabis Users
A new study conducted by University of Cambridge researchers shows that cannabis users and non-users do not demonstrate ...
Loading Comments...